Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, with reference to the G7 pledge of 13 June 2021 on covid-19 vaccines for low income countries, where the vaccines pledged by (a) the UK and (b) the other nations will be manufactured.

The vaccines will be drawn from across the UK's supply of Oxford-AstraZeneca, Pfizer-BioNTech, Janssen, Moderna, and others. Decisions on which vaccines will be shared will be based on the continued reliability of supply chains, regulatory restrictions, and advice from the Joint Committee on Vaccines and Immunisation. We will set out more detail in due course.

The UK has played a leading role in the multilateral efforts to support global vaccination. The most important thing is that leaders work together to ensure equitable access to vaccines. We will build on the Summit's commitments by continuing to engage internationally, including with our G7 partners, on plans that support the ambitious global vaccination targets agreed by the G7. These include efforts to increase supply by working with industry to boost vaccine manufacturing as well as develop future strategies to support COVAX, and develop more sustainable approaches to financing vaccines, and wider future pandemic preparedness.